Cure8

Why This Matters

Fibrosis causes strictures and surgery in many people with Crohn’s disease; a new immune pathway linked to fibrosis could point to future treatments. This study shows that γδ T cells and CD73-mediated adenosine signaling worsen intestinal fibrosis in a mouse model.

Who Should Pay Attention

Researchers studying IBD fibrosis, translational scientists exploring anti-fibrotic targets, and clinicians interested in the biology of fibrostenotic Crohn’s disease.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

The research was conducted in mice with chemically induced chronic colitis and fibrosis (TNBS model). The authors used antibody depletion and adoptive transfer of γδ T cells plus pharmacologic inhibitors/activators of CD73 and cAMP signaling to study effects on fibrosis and related cytokines.

The study suggests targeting the CD73–adenosine receptor–cAMP axis could be a potential anti-fibrotic strategy, but these are preclinical findings in animals—not treatments ready for humans.

Keep In Mind

The article is an experimental animal (mouse) study using TNBS-induced chronic colitis and reports mechanistic findings. These preclinical results need replication and clinical testing before informing patient treatment.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationWorld Journal of Gastroenterology
PublisherBaishideng Publishing Group Inc.
AuthorsLi-Wei Dong, Zhi-Chao Ma, Jiao Fu +5 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedAug 7, 2026, 12:00 AM
Content availableJournal abstract

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →